(Q79774007)
Statements
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML (English)
Bulur PA
Butler GW
Gastineau DA
Hoering A
Fink SR
Letendre L
Padley DJ
Paternoster SF
Tefferi A
Vuk-Pavlović S
1 January 2006